344 related articles for article (PubMed ID: 36211364)
1. Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma.
Gao X; Gao B; Li S
Front Immunol; 2022; 13():1002742. PubMed ID: 36211364
[TBL] [Abstract][Full Text] [Related]
2. The basic characteristics of extracellular vesicles and their potential application in bone sarcomas.
Li S
J Nanobiotechnology; 2021 Sep; 19(1):277. PubMed ID: 34535153
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Roles of Extracellular Vesicles in Osteosarcoma.
Perut F; Roncuzzi L; Baldini N
Front Oncol; 2019; 9():1342. PubMed ID: 31850225
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicle-associated repetitive element DNAs as candidate osteosarcoma biomarkers.
Cambier L; Stachelek K; Triska M; Jubran R; Huang M; Li W; Zhang J; Li J; Cobrinik D
Sci Rep; 2021 Jan; 11(1):94. PubMed ID: 33420117
[TBL] [Abstract][Full Text] [Related]
5. Engineered extracellular vesicles and their mimetics for cancer immunotherapy.
Liu C; Wang Y; Li L; He D; Chi J; Li Q; Wu Y; Zhao Y; Zhang S; Wang L; Fan Z; Liao Y
J Control Release; 2022 Sep; 349():679-698. PubMed ID: 35878728
[TBL] [Abstract][Full Text] [Related]
6. FT-IR Spectral Signature of Sensitive and Multidrug-Resistant Osteosarcoma Cell-Derived Extracellular Nanovesicles.
Perut F; Graziani G; Roncuzzi L; Zini N; Avnet S; Baldini N
Cells; 2022 Feb; 11(5):. PubMed ID: 35269400
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma.
Zhang K; Dong C; Chen M; Yang T; Wang X; Gao Y; Wang L; Wen Y; Chen G; Wang X; Yu X; Zhang Y; Wang P; Shang M; Han K; Zhou Y
Theranostics; 2020; 10(1):411-425. PubMed ID: 31903129
[No Abstract] [Full Text] [Related]
8. Extracellular vesicles and their nucleic acids for biomarker discovery.
Momen-Heravi F; Getting SJ; Moschos SA
Pharmacol Ther; 2018 Dec; 192():170-187. PubMed ID: 30081050
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles.
Mannerström B; Kornilov R; Abu-Shahba AG; Chowdhury IM; Sinha S; Seppänen-Kaijansinkko R; Kaur S
Epigenetics; 2019 Apr; 14(4):352-364. PubMed ID: 30907225
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones.
Macklin R; Wang H; Loo D; Martin S; Cumming A; Cai N; Lane R; Ponce NS; Topkas E; Inder K; Saunders NA; Endo-Munoz L
Oncotarget; 2016 Jul; 7(28):43570-43587. PubMed ID: 27259278
[TBL] [Abstract][Full Text] [Related]
11. mTOR: An attractive therapeutic target for osteosarcoma?
Ding L; Congwei L; Bei Q; Tao Y; Ruiguo W; Heze Y; Bo D; Zhihong L
Oncotarget; 2016 Aug; 7(31):50805-50813. PubMed ID: 27177330
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles from Highly Metastatic Osteosarcoma Cells Induce Pro-Tumorigenic Macrophage Phenotypes.
Griffin KH; Mizenko RR; Arun V; Carney RP; Leach JK
Adv Biol (Weinh); 2024 Jun; 8(6):e2300577. PubMed ID: 38596830
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicle RNA Sequencing Reveals Dramatic Transcriptomic Alterations Between Metastatic and Primary Osteosarcoma in a Liquid Biopsy Approach.
Bao Q; Gong L; Wang J; Wen J; Shen Y; Zhang W
Ann Surg Oncol; 2018 Sep; 25(9):2642-2651. PubMed ID: 29981024
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential extracellular vesicle protein markers altered in osteosarcoma from public databases.
Zhang J; Li H
Proteomics Clin Appl; 2023 Jul; 17(4):e2200084. PubMed ID: 36571514
[TBL] [Abstract][Full Text] [Related]
15. Proteomic Assessment of Extracellular Vesicles from Canine Tissue Explants as a Pipeline to Identify Molecular Targets in Osteosarcoma: PSMD14/Rpn11 as a Proof of Principle.
Luu AK; Cadieux M; Wong M; Macdonald R; Jones R; Choi D; Oblak M; Brisson B; Sauer S; Chafitz J; Warshawsky D; Wood GA; Viloria-Petit AM
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328679
[TBL] [Abstract][Full Text] [Related]
16. The application of extracellular vesicles in colorectal cancer metastasis and drug resistance: recent advances and trends.
Xiong L; Wei Y; Jia Q; Chen J; Chen T; Yuan J; Pi C; Liu H; Tang J; Yin S; Zuo Y; Zhang X; Liu F; Yang H; Zhao L
J Nanobiotechnology; 2023 Apr; 21(1):143. PubMed ID: 37120534
[TBL] [Abstract][Full Text] [Related]
17. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma-derived extracellular vesicles induce a tumor-like phenotype in normal recipient cells.
Urciuoli E; Giorda E; Scarsella M; Petrini S; Peruzzi B
J Cell Physiol; 2018 Aug; 233(8):6158-6172. PubMed ID: 29323709
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents?
De Martino V; Rossi M; Battafarano G; Pepe J; Minisola S; Del Fattore A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830463
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous Analysis of Extracellular Vesicles for Osteosarcoma Diagnosis.
Zhai C; Xu J; Yang Y; Xie F; Cao L; Wang K; Zhou Y; Ding X; Yin J; Ding X; Hu H; Yu H
Anal Chem; 2024 Jun; 96(23):9486-9492. PubMed ID: 38814722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
